Evaluation of a combined online and in person training in the use of buprenorphine

Substance Abuse

Volumn 27, Issue 3, 2006, Pages 39-45

  Gunderson, Erik W ^a,c   Fiellin, David A ^b   Levin, Frances R ^a   Sullivan, Lynn E ^b   Kleber, Herbert D ^a  

^a New York State Psychiatric Institute ^*  (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Buprenorphine; Medical education; Opioid dependence; Training

Indexed keywords

BUPRENORPHINE;

CLINICAL PRACTICE; DRUG DEPENDENCE TREATMENT; GENERAL PRACTITIONER; MEDICAL EDUCATION; PHYSICIAN ATTITUDE; PRESCRIPTION; PSYCHIATRIST; REIMBURSEMENT; REVIEW; TRAINING;

ADULT; BUPRENORPHINE; COMPUTER-ASSISTED INSTRUCTION; CURRICULUM; EDUCATION, MEDICAL; FELLOWSHIPS AND SCHOLARSHIPS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INSERVICE TRAINING; INTERNET; INTERNSHIP AND RESIDENCY; MALE; NARCOTICS; OPIOID-RELATED DISORDERS; PRESCRIPTIONS, DRUG;

EID: 33751266504     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1300/J465v27n03_06     Document Type: Review

References (12)

1. Office of National Drug Control Policy. Drug Policy Information Clearinghouse Fact Sheet: Heroin. June 2003; Accessed August 1, 2005. Available: http://www.whitehousedrugpolicy.gov/publications/factsht/heroin/index.html
2. Substance Abuse and Mental Health Services Administration. Results from the 2003 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-25, DHHS Publications No. SMA 04-3964). 2004; Rockville, MD.
3. Substance Abuse and Mental Health Services Administration. Alcohol and Drug Services Study (ADSS). The National Treatment System: Outpatient Methadone Facilities. Office of Applied Studies. 2004; Rockville, MD. Available: http://oas.samhsa.gov/ADSS/methadone. pdf
4. Clark HW: Office-based practice and opioid-use disorders. N. Engl J Med 2003; 349: 928-930.
5. Substance Abuse and Mental Health Services Administration. Frequently Asked Questions About Buprenorphine and the Drug Addiction Treatment Act of 2000 (DATA). 2005; Accessed October 2005. Available: http://buprenorphine.samhsa. gov/faq.html
6. National Poll of Physicians Finds Barriers to Widespread Buprenorphine Use. Join Together 2003; Accessed September 2004. Available: http://www. jointogether.org/sa/files/pdf/bupereport.pdf
7. Levin FR, Gunderson EW, Levounis P: Medical Education. In: Galanter M and Kleber HD, eds. The American Psychiatric Publishing Textbook of Substance Abuse Treatment. Washington, DC: American Psychiatric Press; 2004:597-609.
8. Center for Substance Abuse Treatment (2004). Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. Rockville, MD, Substance Abuse and Mental Health Services Administration.
9. Friedman PD, McCullough D, Saitz R: Screening and intervention for illicit drug abuse: a national survey of primary care physicians and psychiatrists. Arch Intern Med 2001; 161:248-251.
10. Fiellin DA, O'Connor PG: Clinical practice. Office-based treatment of opioid-dependent patients. N Engl J Med 2002; 347(11):817-823.
11. Lintzeris N, Ritter A, Dunlop A, Muhleisen P. Training primary health care professionals to provide buprenorphine and LAAM treatment. Substance Abuse (2002); 23(4):245-254.
12. Wong JG, Holmboe ES, Jara GB, Martin J, Becker WC, Fiellin DA. Faculty development in small-group teaching skills associated with a training course on office-based treatment of opioid dependence. Substance Abuse 2005; 25(4):35-40.